DP

Diadema Partners Portfolio holdings

AUM $161M
This Quarter Est. Return
1 Year Est. Return
–
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$161M
AUM Growth
+$35.7M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
94
New
Increased
Reduced
Closed

Top Buys

1
+$16M
2
+$14.5M
3
+$7.7M
4
TGTX icon
TG Therapeutics
TGTX
+$5.89M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$4.45M

Top Sells

1
+$12.7M
2
+$3.54M
3
+$3.5M
4
ARGX icon
argenx
ARGX
+$3.48M
5
RYTM icon
Rhythm Pharmaceuticals
RYTM
+$2.65M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RVPH icon
26
Reviva Pharmaceuticals
RVPH
$55.4M
$1.04M 0.32%
2,735,457
+2,084,734
MNMD icon
27
MindMed
MNMD
$1.04B
$1.03M 0.31%
+158,536
TRVI icon
28
Trevi Therapeutics
TRVI
$1.26B
$1.02M 0.31%
185,830
+5,830
TERN icon
29
Terns Pharmaceuticals
TERN
$736M
$969K 0.3%
259,852
+203,754
ETNB icon
30
89bio
ETNB
$2.19B
$966K 0.29%
98,382
-133,054
CLYM
31
Climb Bio
CLYM
$131M
$871K 0.27%
702,135
+32,332
SCPH
32
DELISTED
scPharmaceuticals
SCPH
$829K 0.25%
+217,623
VTGN icon
33
VistaGen Therapeutics
VTGN
$124M
$808K 0.25%
403,922
-162,053
ARVN icon
34
Arvinas
ARVN
$699M
$710K 0.22%
+96,455
APGE icon
35
Apogee Therapeutics
APGE
$3.73B
$459K 0.14%
10,572
-29,428
PHAT icon
36
Phathom Pharmaceuticals
PHAT
$919M
$386K 0.12%
+40,294
NUVL icon
37
Nuvalent
NUVL
$6.67B
$382K 0.12%
+5,000
ALEC icon
38
Alector
ALEC
$308M
$372K 0.11%
266,023
-190,523
PRQR icon
39
ProQR Therapeutics
PRQR
$293M
$322K 0.1%
157,694
-50,000
REPL icon
40
Replimune Group
REPL
$351M
$302K 0.09%
32,483
-42,047
ELDN icon
41
Eledon Pharmaceuticals
ELDN
$206M
$175K 0.05%
64,613
RLAY icon
42
Relay Therapeutics
RLAY
$1.12B
$151K 0.05%
43,616
-382,730
ELEV
43
DELISTED
Elevation Oncology
ELEV
$133K 0.04%
+362,935
PRTC
44
PureTech Health
PRTC
$435M
$126K 0.04%
+7,324
SMMT icon
45
Summit Therapeutics
SMMT
$15.6B
$19.8K 0.01%
+932
ZLAB icon
46
Zai Lab
ZLAB
$3.15B
$13.2K ﹤0.01%
+3,785
ACAD icon
47
Acadia Pharmaceuticals
ACAD
$3.52B
– –
0
AGIO icon
48
Agios Pharmaceuticals
AGIO
$2.46B
– –
0
ALNY icon
49
Alnylam Pharmaceuticals
ALNY
$63.1B
– –
-13,115
ALT icon
50
Altimmune
ALT
$338M
– –
0
1
2
3 4